424 related articles for article (PubMed ID: 18405746)
1. Commentary on prostate and urothelial carcinoma in cystoprostatectomy specimens.
Lotan Y
J Urol; 2008 May; 179(5 Suppl):S33-4. PubMed ID: 18405746
[No Abstract] [Full Text] [Related]
2. Editorial comment.
Skinner EC
Urology; 2010 May; 75(5):1120; author reply 1120-1. PubMed ID: 20451729
[No Abstract] [Full Text] [Related]
3. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
[TBL] [Abstract][Full Text] [Related]
4. Developing selection criteria for prostate-sparing cystectomy: a review of cystoprostatectomy specimens.
Richards KA; Parks GE; Badlani GH; Kader AK; Hemal AK; Pettus JA
Urology; 2010 May; 75(5):1116-20. PubMed ID: 20080289
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous laparoscopic management of 3 urological malignancies.
Deng DY; Meng MV; Grossfeld GD; Stoller ML
J Urol; 2002 May; 167(5):2125-6. PubMed ID: 11956456
[No Abstract] [Full Text] [Related]
6. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder.
Moutzouris G; Barbatis C; Plastiras D; Mertziotis N; Katsifotis C; Presvelos V; Theodorou C
Scand J Urol Nephrol; 1999 Feb; 33(1):27-30. PubMed ID: 10100360
[TBL] [Abstract][Full Text] [Related]
7. [Prostate cancer incidence on specimen of cystoprostatectomy for infiltrative bladder cancer].
Zerbib M; Bouchot O
Prog Urol; 2005 Dec; 15(6 Suppl 1):1262-5. PubMed ID: 16734215
[No Abstract] [Full Text] [Related]
8. Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer.
Mazzucchelli R; Barbisan F; Santinelli A; Scarpelli M; Galosi AB; Lopez-Beltran A; Cheng L; Kirkali Z; Montironi R
Urology; 2009 Aug; 74(2):385-90. PubMed ID: 19501882
[TBL] [Abstract][Full Text] [Related]
9. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
[TBL] [Abstract][Full Text] [Related]
10. [Prostatic urothelial location of a tumor of the bladder].
Coulange C; Lechevallier E; de Fromont M
Prog Urol; 1997 Feb; 7(1):128-31. PubMed ID: 9116731
[TBL] [Abstract][Full Text] [Related]
11. [Detection of a prostatic adenocarcinoma in the cysto-prostatectomy specimens of an invasive tumor of the bladder].
Baron JC; Zerbib M; Levêque JM; Deslignières S; Boccon-Gibod L; Debré B; Steg A
Ann Urol (Paris); 1989; 23(2):119-22. PubMed ID: 2742333
[TBL] [Abstract][Full Text] [Related]
12. Relevance of prostate cancer in patients with synchronous invasive bladder urothelial carcinoma: a monocentric retrospective analysis.
Dell'Atti L
Arch Ital Urol Androl; 2015 Mar; 87(1):76-9. PubMed ID: 25847902
[TBL] [Abstract][Full Text] [Related]
13. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens.
Bruins HM; Djaladat H; Ahmadi H; Sherrod A; Cai J; Miranda G; Skinner EC; Daneshmand S
J Urol; 2013 Nov; 190(5):1704-9. PubMed ID: 23707451
[TBL] [Abstract][Full Text] [Related]
14. Urothelial carcinoma of the prostate.
Goebbels R; Amberger L; Wernert N; Dhom G
Appl Pathol; 1985; 3(4):242-54. PubMed ID: 3842265
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection.
Liedberg F; Anderson H; Bläckberg M; Chebil G; Davidsson T; Gudjonsson S; Jahnson S; Olsson H; Månsson W
Scand J Urol Nephrol; 2007; 41(4):290-6. PubMed ID: 17763219
[TBL] [Abstract][Full Text] [Related]
16. Concomitant pathology in the prostate in cystoprostatectomy specimens: a prospective study and review.
Saad M; Abdel-Rahim M; Abol-Enein H; Ghoneim MA
BJU Int; 2008 Dec; 102(11):1544-50. PubMed ID: 18565169
[TBL] [Abstract][Full Text] [Related]
17. Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinoma.
Arce J; Gaya JM; Huguet J; Rodriguez O; Palou J; Villavicencio H
Can J Urol; 2011 Feb; 18(1):5529-36. PubMed ID: 21333045
[TBL] [Abstract][Full Text] [Related]
18. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
Frazier HA; Robertson JE; Dodge RK; Paulson DF
Cancer; 1993 Jun; 71(12):3993-4001. PubMed ID: 8508365
[TBL] [Abstract][Full Text] [Related]
19. Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancer.
Lerner SP; Shen S
Urol Oncol; 2008; 26(5):481-5. PubMed ID: 18774459
[TBL] [Abstract][Full Text] [Related]
20. Synchronous primary carcinomas of the bladder and prostate.
Lee SH; Chang PL; Chen SM; Sun GH; Chen CL; Shen BY; Wu YS; Tsui KH
Asian J Androl; 2006 May; 8(3):357-9. PubMed ID: 16625287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
